HLA-DR antigens show restricted tissue distribution in comparison with
the more extensive expression of HLA class I molecules. This constitu
tive expression is genetically controlled by well-defined mechanisms.
In addition, DR antigen expression can be induced by a variety of cyto
kines through different molecular genetic events that convert DR-negat
ive epithelia into positive cells. In this review we analyse the two m
ajor pathological situations in which abnormal DR expression occurs: a
utoimmune diseases and tumour development. We hypothesize that convers
ion to DR-positivity may produce two opposite effects in both clinical
situations: (1) a useful one in tumours associated with a good progno
sis; and (2) a harmful one in autoimmune diseases with increased tissu
e damage.